Drug Shortage Report for AURO-ALENDRONATE

Last updated on 2024-10-16 History
Report ID 235870
Drug Identification Number 02388545
Brand name AURO-ALENDRONATE
Common or Proper name AURO-ALENDRONATE
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) ALENDRONIC ACID
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100's
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2024-08-26
Estimated end date 2024-10-15
Actual end date 2024-10-15
Shortage status Resolved
Updated date 2024-10-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Anahita Rostami

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2024-10-16 English Compare
v9 2024-10-15 French Compare
v8 2024-10-15 English Compare
v7 2024-09-27 French Compare
v6 2024-09-27 English Compare
v5 2024-09-13 French Compare
v4 2024-09-13 English Compare
v3 2024-08-27 English Compare
v2 2024-08-26 French Compare
v1 2024-08-26 English Compare

Showing 1 to 10 of 10